Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study.
Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study.
复制标题
DOI:
10.1016/j.ijid.2021.07.016
复制
发表时间:
2021-08
期刊:
影响因子:
--
通讯作者:
Guiot J
中科院分区:
文献类型:
--
作者:
Darcis G;Bouquegneau A;Maes N;Thys M;Henket M;Labye F;Rousseau AF;Canivet P;Desir C;Calmes D;Schils R;De Worm S;Léonard P;Meunier P;Moutschen M;Louis R;Guiot J
Various symptoms and considerable organ dysfunction persist following infection with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). Uncertainty remains about the potential mid- and long-term health sequelae. This prospective study of patients hospitalized with coronavirus disease 2019 (COVID-19) in Liège University Hospital, Belgium aimed to determine the persistent consequences of COVID-19. Patients admitted to the University Hospital of Liège with moderate-to-severe confirmed COVID-19, discharged between 2 March and 1 October 2020, were recruited prospectively. Follow-up at 3 and 6 months after hospital discharge included demographic and clinical data, biological data, pulmonary function tests (PFTs) and high-resolution computed tomography (CT) scans of the chest. In total, 199 individuals were included in the analysis. Most patients received oxygen supplementation (80.4%). Six months after discharge, 47% and 32% of patients still had exertional dyspnoea and fatigue. PFTs at 3-month follow-up revealed a reduced diffusion capacity of carbon monoxide (mean 71.6 ± 18.6%), and this increased significantly at 6-month follow-up (P<0.0001). Chest CT scans showed a high prevalence (68.9% of the cohort) of persistent abnormalities, mainly ground glass opacities. Duration of hospitalization, intensive care unit admission and mechanical ventilation were not associated with the persistence of symptoms 3 months after discharge. The prevalence of persistent symptoms following hospitalization with COVID-19 is high and stable for up to 6 months after discharge. However, biological, functional and iconographic abnormalities improved significantly over time.
登录
查看更多内容
影响因子:
4.6
作者:
Kashif A;Chaudhry M;Fayyaz T;Abdullah M;Malik A;Anwer JMA;Inam SHA;Fatima T;Iqbal N;Shoaib K
通讯作者:
Shoaib K
DOI:
10.1186/cc11454
发表时间:
2013-02-04
期刊:
Critical care (London, England)
影响因子:
--
作者:
Kellum JA;Lameire N;KDIGO AKI Guideline Work Group
通讯作者:
KDIGO AKI Guideline Work Group
影响因子:
6
作者:
Charytan DM;Parnia S;Khatri M;Petrilli CM;Jones S;Benstein J;Horwitz LI
通讯作者:
Horwitz LI
影响因子:
13.8
作者:
Bellan M;Soddu D;Balbo PE;Baricich A;Zeppegno P;Avanzi GC;Baldon G;Bartolomei G;Battaglia M;Battistini S;Binda V;Borg M;Cantaluppi V;Castello LM;Clivati E;Cisari C;Costanzo M;Croce A;Cuneo D;De Benedittis C;De Vecchi S;Feggi A;Gai M;Gambaro E;Gattoni E;Gramaglia C;Grisafi L;Guerriero C;Hayden E;Jona A;Invernizzi M;Lorenzini L;Loreti L;Martelli M;Marzullo P;Matino E;Panero A;Parachini E;Patrucco F;Patti G;Pirovano A;Prosperini P;Quaglino R;Rigamonti C;Sainaghi PP;Vecchi C;Zecca E;Pirisi M
通讯作者:
Pirisi M
影响因子:
64.8
作者:
Al-Aly, Ziyad;Xie, Yan;Bowe, Benjamin
通讯作者:
Bowe, Benjamin